Prophylaxie post-exposition au VIH : Maladies infectieuses = Post-exposure prophylaxis against HIVDE LUCIA, Sylvain; HIRSCHEL, Bernard.Revue médicale de la Suisse romande. 2003, Vol 123, Num 3, pp 159-164, issn 0035-3655, 6 p.Article

Supervised interruptions of antiretroviral therapyDEEKS, Steven G; HIRSCHEL, Bernard.AIDS (London). 2002, Vol 16, pp S157-S169, issn 0269-9370, SUP4Article

Late presentation of HIV-infected individualsBATTEGAY, Manuel; FLUCKIGER, Ursula; HIRSCHEL, Bernard et al.Antiviral therapy (London). 2007, Vol 12, Num 6, pp 841-851, issn 1359-6535, 11 p.Article

The Monark trial : where now for boosted protease inhibitor monotherapy?HILL, Andrew; HIRSCHEL, Bernard; KATLAMA, Christine et al.AIDS (London). 2008, Vol 22, Num 6, pp 777-779, issn 0269-9370, 3 p.Article

A new era of antiretroviral drug toxicityCALMY, Alexandra; HIRSCHEL, Bernard; COOPER, David A et al.Antiviral therapy (London). 2009, Vol 14, Num 2, pp 165-179, issn 1359-6535, 15 p.Article

PEP ou pas PEP ? Du rationnel de l'emploi des prophylaxies postexpositionnelles : Maladies infectieuses = PEP or no PEP ? The rational of initiating postexposure prophylaxisEL AMARI, Emmanuelle Boffi; HIRSCHEL, Bernard; ITEN, Anne et al.Revue médicale suisse. 2008, Vol 4, Num 152, issn 1660-9379, 894-900 [4 p.]Article

Immunological recovery and antiretroviral therapy in HIV-1 infectionBATTEGAY, Manuel; NUESCH, Reto; HIRSCHEL, Bernard et al.Lancet. Infectious diseases (print). 2006, Vol 6, Num 5, pp 280-287, issn 1473-3099, 8 p.Article

Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study, by Matthews et alHIRSCHEL, Bernard.AIDS (Supplement). 2003, Vol 17, pp S116-S117, issn 1350-2840, SUP4Article

Is transmission of HIV-1 in non-viraemic serodiscordant couples possible?VERNAZZA, Pietro L; HIRSCHEL, Bernard; STÜRMER, Martin et al.Antiviral therapy (London). 2008, Vol 13, Num 5, issn 1359-6535, 641-642, 729-732 [6 p.]Article

Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infectionYERLY, Sabine; PERNEGER, Thomas V; VORA, Samir et al.AIDS (London). 2000, Vol 14, Num 18, pp 2805-2812, issn 0269-9370Article

Dix ans de lipodystrophie (1998-2008) : un syndrome encore méconnu = 10 years of lipodystrophy -and so many uncertainesCALMY, Alexandra; HIRSCHEL, Bernard; TOUTOUS-TRELLU, Laurence et al.Revue médicale suisse. 2008, Vol 4, Num 184, pp 2755-2757, issn 1660-9379, 3 p.Article

HIV entry inhibitors. CommentaryCALMY, Alexandro; HIRSCHEL, Bernard; COOPER, David A et al.Lancet (British edition). 2007, Vol 370, Num 9581, issn 0140-6736, 12-14, 81-88 [11 p.]Article

The Trap: Professional Exposure to Human Immunodeficiency Virus Antibody-Negative Blood With High Viral LoadGIULIERI, Stefano; SCHIFFER, Veronique; YERLY, Sabine et al.Archives of internal medicine (1960). 2007, Vol 167, Num 22, pp 2524-2526, issn 0003-9926, 3 p.Article

L-Ornithine α-ketoglutarate in HIV infection: Effects on muscle, gastrointestinal, and immune functionsKARSEGARD, Veronique L; RAGUSO, Comasia A; GENTON, Laurence et al.Nutrition (Burbank, Los Angeles County, Calif.). 2004, Vol 20, Num 6, pp 515-520, issn 0899-9007, 6 p.Article

Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapyCALMY, Alexandra; HIRSCHEL, Bernard; HANS, Didier et al.AIDS (London). 2003, Vol 17, Num 5, pp 770-772, issn 0269-9370, 3 p.Article

Nouveau Spectre des troubles cognitifs liés à l'infection par le VIH à l'ère des trithérapies : Neurologie = New spectrum of HIV-associated cognitive disorders in the HAART eraDU PASQUIER, Renaud; ANNONI, Jean-Marie; SIMIONI, Samanta et al.Revue médicale suisse. 2009, Vol 5, Num 201, issn 1660-9379, 955-961 [6 p.]Article

A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy, by Cohen et alHIRSCHEL, Bernard.AIDS (Supplement). 2003, Vol 17, pp S114-S116, issn 1350-2840, SUP4Article

Incidence of HIV-1 Drug Resistance Among Antiretroviral Treatment―Naive Individuals Starting Modern Therapy CombinationsVON WYL, Viktor; YERLY, Sabine; HIRSCHEL, Bernard et al.Clinical infectious diseases. 2012, Vol 54, Num 1, pp 131-140, issn 1058-4838, 10 p.Article

Low Bone Mineral Density, Renal Dysfunction, and Fracture Risk in HIV Infection: A Cross-Sectional StudyCALMY, Alexandra; FUX, Christoph A; NORRIS, Richard et al.The Journal of infectious diseases. 2009, Vol 200, Num 11, pp 1746-1754, issn 0022-1899, 9 p.Article

Durability and Outcome of Initial Antiretroviral Treatments Received during 2000-2005 by Patients in the Swiss HIV Cohort StudyTHI TUYET NHUNG VO; LEDERGERBER, Bruno; KEISER, Olivia et al.The Journal of infectious diseases. 2008, Vol 197, Num 12, pp 1685-1694, issn 0022-1899, 10 p.Article

Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infectionNÜESCH, Reto; ANANWORANICH, Jintanat; SRASUEBKUL, Preeyaporn et al.AIDS (London). 2008, Vol 22, Num 1, pp 152-154, issn 0269-9370, 3 p.Article

Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavirANANWORANICH, Jintanat; GAYET-AGERON, Angele; JUPIMAI, Thidarat et al.Antiviral therapy (London). 2008, Vol 13, Num 3, pp 375-380, issn 1359-6535, 6 p.Article

Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimenFOX, Zoe; PHILLIPS, Andrew; COHERE, Cal et al.AIDS (London). 2008, Vol 22, Num 17, pp 2279-2289, issn 0269-9370, 11 p.Article

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine : the Swiss HIV Cohort StudyWOLBERS, Marcel; OPRAVIL, Milos; GÜNTHARD, Huldrych et al.AIDS (London). 2007, Vol 21, Num 16, pp 2201-2207, issn 0269-9370, 7 p.Article

Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy : findings from the swiss HIV cohort studySIMCOCK, Mathew; BLASKO, Monika; MOIRANDAT-RYTZ, Sophie et al.Antiviral therapy (London). 2007, Vol 12, Num 6, pp 931-939, issn 1359-6535, 9 p.Article